Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Magazine

Table: Exposing Massive Foul Play at TAP


FIRST SUSPICIONS

Durand's concerns began soon after he joined: He asked to meet TAP's in-house counsel and was told the company didn't have one. Some 10 months later, he began documenting fraud at TAP.

WHAT HE FOUND

Sales reps for TAP's drug Lupron had offered every urologist in the country a big-screen TV. Worse, they handed out Lupron at cut-rate prices or gratis while inflating the Medicare-reimbursement price.

THE RESULT

In 2001, the federal government won an $875 million judgment against TAP. Four doctors pleaded guilty to fraud and await sentencing. Six TAP execs and one doctor face trial for conspiracy to commit fraud.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus